Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

mckesson corp. - MCK

MCK

Close Chg Chg %
764.03 10.35 1.35%

Open Market

774.38

+10.35 (1.35%)

Volume: 372.18K

Last Updated:

Jun 24, 2026, 1:21 PM EDT

Trade Now

Company Overview: mckesson corp. - MCK

MCK Key Data

Open

$766.85

 Day Range

762.45 - 777.80

52 Week Range

637.00 - 999.00

 Market Cap

$89.44B

Shares Outstanding

117.08M

 Public Float

116.76M

Beta

0.31

 Rev. Per Employee

N/A

P/E Ratio

19.91

 EPS

$38.63

Yield

41.50%

 Dividend

$0.82

EX-DIVIDEND DATE

Jun 1, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.14M

  

MCK Performance

1 Week
 
 1.77%
 
1 Month
 
 -0.28%
 
3 Months
 
 -11.19%
 
1 Year
 
 5.25%
 
5 Years
 
 299.24%
 

MCK Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

About mckesson corp. - MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

MCK At a Glance

McKesson Corp.
6555 State Highway 161
Irving, Texas 75039
Phone 1-972-446-4800 Revenue 403.43B
Industry Medical Distributors Net Income 4.76B
Sector Distribution Services 2026 Sales Growth 12.36%
Fiscal Year-end 03 / 2027 Employees 43,000
View SEC Filings

MCK Valuation

P/E Current 19.908
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 22.552
Price to Sales Ratio 0.266
Price to Book Ratio N/A
Price to Cash Flow Ratio 17.45
Enterprise Value to EBITDA 16.957
Enterprise Value to Sales 0.281
Total Debt to Enterprise Value 0.076

MCK Efficiency

Revenue/Employee 9,382,093.023
Income Per Employee 110,744.186
Receivables Turnover 14.416
Total Asset Turnover 5.124

MCK Liquidity

Current Ratio 0.854
Quick Ratio 0.492
Cash Ratio 0.061

MCK Profitability

Gross Margin 3.484
Operating Margin 1.475
Pretax Margin 1.537
Net Margin 1.18
Return on Assets 6.048
Return on Equity N/A
Return on Total Capital 73.921
Return on Invested Capital 108.784

MCK Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 133.716
Total Debt to Total Assets 10.464
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 109.593
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Mckesson Corp. - MCK

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
276.71B 308.95B 359.05B 403.43B
Sales Growth
+4.83% +11.65% +16.22% +12.36%
Cost of Goods Sold (COGS) incl D&A
264.84B 296.75B 346.57B 389.38B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
857.00M 635.00M 636.00M 729.00M
Depreciation
497.00M 253.00M 242.00M 256.00M
Amortization of Intangibles
360.00M 382.00M 394.00M 473.00M
COGS Growth
+5.38% +12.05% +16.79% +12.35%
Gross Income
11.87B 12.20B 12.48B 14.05B
Gross Income Growth
-6.17% +2.81% +2.32% +12.57%
Gross Profit Margin
+4.29% +3.95% +3.48% +3.48%
2023 2024 2025 2026 5-year trend
SG&A Expense
7.42B 8.28B 8.11B 8.10B
Research & Development
89.00M 77.00M 91.00M 103.00M
Other SG&A
7.33B 8.20B 8.02B 8.00B
SGA Growth
-25.29% +11.58% -1.96% -0.12%
Other Operating Expense
- - - -
-
Unusual Expense
(257.00M) 51.00M (99.00M) 213.00M
EBIT after Unusual Expense
4.71B 3.88B 4.47B 5.74B
Non Operating Income/Expense
168.00M 156.00M 144.00M 710.00M
Non-Operating Interest Income
107.00M 118.00M 173.00M 179.00M
Equity in Earnings of Affiliates
5.00M 4.00M 9.00M 7.00M
Interest Expense
248.00M 243.00M 256.00M 247.00M
Interest Expense Growth
+39.33% -2.02% +5.35% -3.52%
Gross Interest Expense
248.00M 243.00M 256.00M 247.00M
Interest Capitalized
- - - -
-
Pretax Income
4.63B 3.79B 4.36B 6.20B
Pretax Income Growth
+140.15% -18.16% +15.04% +42.26%
Pretax Margin
+1.67% +1.23% +1.21% +1.54%
Income Tax
905.00M 629.00M 878.00M 1.10B
Income Tax - Current - Domestic
745.00M 1.10B 734.00M 654.00M
Income Tax - Current - Foreign
180.00M 134.00M 254.00M 218.00M
Income Tax - Deferred - Domestic
(10.00M) (493.00M) 107.00M 305.00M
Income Tax - Deferred - Foreign
(10.00M) (110.00M) (217.00M) (75.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
5.00M 4.00M 9.00M 7.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
3.73B 3.16B 3.48B 5.10B
Minority Interest Expense
162.00M 158.00M 186.00M 337.00M
Net Income
3.56B 3.00B 3.29B 4.76B
Net Income Growth
+218.41% -15.75% +9.76% +44.52%
Net Margin Growth
+1.29% +0.97% +0.92% +1.18%
Extraordinaries & Discontinued Operations
- - - (3.00M)
-
Discontinued Operations
- - - (3.00M)
-
Net Income After Extraordinaries
3.56B 3.00B 3.29B 4.76B
Preferred Dividends
- - - -
-
Net Income Available to Common
3.56B 3.00B 3.29B 4.76B
EPS (Basic)
25.2303 22.5375 25.8634 38.5275
EPS (Basic) Growth
+244.94% -10.67% +14.76% +48.97%
Basic Shares Outstanding
141.10M 133.20M 127.40M 123.60M
EPS (Diluted)
25.0352 22.3863 25.7221 38.3723
EPS (Diluted) Growth
+246.31% -10.58% +14.90% +49.18%
Diluted Shares Outstanding
142.20M 134.10M 128.10M 124.10M
EBITDA
5.31B 4.56B 5.01B 6.68B
EBITDA Growth
+42.59% -14.09% +9.78% +33.39%
EBITDA Margin
+1.92% +1.48% +1.39% +1.66%

Snapshot

Average Recommendation BUY Average Target Price 948.267
Number of Ratings 21 Current Quarters Estimate 9.645
FY Report Date 06 / 2026 Current Year's Estimate 44.26
Last Quarter’s Earnings 11.69 Median PE on CY Estimate N/A
Year Ago Earnings 39.11 Next Fiscal Year Estimate 50.387
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 18 16
Mean Estimate 9.65 10.75 44.26 50.39
High Estimates 9.90 11.13 44.55 52.44
Low Estimate 9.25 10.42 43.88 49.54
Coefficient of Variance 1.90 1.69 0.38 1.51

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 15 15 12
OVERWEIGHT 4 4 4
HOLD 2 2 3
UNDERWEIGHT 0 0 1
SELL 0 0 0
MEAN Buy Buy Overweight

Insider Actions for Mckesson Corp. - MCK

Date Name Shares Transaction Value
Jun 19, 2026 Brian Scott Tyler Chief Executive Officer; Director 14,382 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $775.13 per share 11,147,919.66
May 28, 2026 Napoleon B. Rutledge SVP, Controller & CAO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 LeAnn B. Smith EVP & Chief HR Officer 6,876 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 LeAnn B. Smith EVP & Chief HR Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 Britt J. Vitalone EVP & CFO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 Britt J. Vitalone EVP & CFO 21,953 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $766.08 per share 16,817,754.24
May 28, 2026 Britt J. Vitalone EVP & CFO 22,534 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 Francisco Fraga EVP, CIO and CTO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 Francisco Fraga EVP, CIO and CTO 6,210 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $766.08 per share 4,757,356.80
May 28, 2026 Francisco Fraga EVP, CIO and CTO 6,264 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 Napoleon B. Rutledge SVP, Controller & CAO 765 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $766.08 per share 586,051.20
May 28, 2026 Napoleon B. Rutledge SVP, Controller & CAO 806 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 LeAnn B. Smith EVP & Chief HR Officer 6,608 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $766.08 per share 5,062,256.64
May 28, 2026 Tom Rodgers EVP, Chief Strategy & BDO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 Tom Rodgers EVP, Chief Strategy & BDO 3,090 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $761.09 per share 2,351,768.10
May 28, 2026 Tom Rodgers EVP, Chief Strategy & BDO 5,478 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $766.08 per share 4,196,586.24
May 28, 2026 Tom Rodgers EVP, Chief Strategy & BDO 5,712 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 Brian Scott Tyler Chief Executive Officer; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 28, 2026 Brian Scott Tyler Chief Executive Officer; Director 27,774 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $766.08 per share 21,277,105.92
May 27, 2026 Michele M. Lau EVP and Chief Legal Officer 7,082 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Mckesson Corp. in the News